Researchers uncover dual role of B7-H3 in prostate tumor immune suppression
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown pathway that prostate tumors leverage to suppress the immune system by reshaping the tumor microenvironment to resist treatment. A combined targeted therapy approach improved antitumor responses and prolonged survival in preclinical models of castration-resistant prostate cancer.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Overprescribing can take a toll on older people's health and independence—here's what can be done
-
Beetroot juice may make swimming feel easier without making swimmers faster
-
Happy at work, better at the job? A study of young employees offers clues
-
Long-acting injectable antipsychotics provide better outcomes in bipolar disorder and older schizophrenia patients
-
Nursing home beds are becoming more scarce
-
Air pollution and cardiovascular disease: Mitochondria may be the missing link
-
New polymer could enable gastrointestinal transit monitoring without ionizing radiation
-
How stores choose what to put on their shelves — like, say, Planet Money's board game